Validation of the Italian version of the Infants' Dermatitis Quality of Life and Family Dermatitis Indexes

Giornale Italiano di Dermatologia e Venereologia

Volumn 142, Issue 5, 2007, Pages 423-432

  Baranzoni, N ^a   Scalone, L ^b,c   Mantovani, L G ^b,c   De Portu, S ^c   Monzini, M S ^b   Giannetti, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Dermatitis Family Impact; Dermatitis, atopic; Infants' Dermatitis Quality of Life; Quality of life; Questionnaires

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INTERVIEW; ITALY; MALE; ONSET AGE; PSYCHOMOTOR RETARDATION; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SYMPTOM;

EID: 37049034222     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003;21:105-13.
2. Finlay AY, Ryan TJ. Disability and handicap in dermatology. Int J Dermatol 1996;35:305-11.
3. Ryan TJ. Disability in dermatology. Br J Hosp Med 1991;46:33-6.
4. Jowett S, Ryan TJ. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-9.
5. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-9.
6. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a Simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
7. Lewis V, Finlay AY. 10 Years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9:169-80.
8. Lawson V, Lewis-Joines MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: Dermatitis Family Impact Questionnaire. Br J Dermatol 1998;138:107-13.
9. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Control Clin Trials 1991;12:142S-158S.
10. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taied A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-9.
11. http://www.dermatology.org.uk
12. Lawrence I-Kuei L. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
13. Cohen J. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-20.
14. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational and Psychological Measurement 1973;33:613-9.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
16. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:59-74.
17. British Standard Institution. Precision of test methods I: Guide for the determination and reproducibility for a standard test method (BS 5497, part 1). London: BSI; 1979.
18. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.